← DAKTRONICS INC /SD/
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Net Income (Loss) Attributable to Parent | $2.1m |
$10.3m
+401.80%
|
$5.6m
-46.22%
|
($958k)
-117.22%
|
$491k
+151.25%
|
$10.9m
+2125.25%
|
$592k
-94.58%
|
$6.8m
+1048.99%
|
$34.6m
+408.98%
|
($10.1m)
-129.23%
|
— | |
| Depreciation, Depletion and Amortization | $16.9m | $19.4m | $17.8m | $18.6m | $17.7m | $17.1m | $15.4m | $17.0m | $19.3m | $19.5m | $19.3m | |
| Amortization | $295k | — | — | — | — | — | — | — | — | — | — | |
| Amortization of Debt Issuance Costs | — | — | — | — | — | — | $0 | $0 | $1.6m | $1.6m | — | |
| Amortization of Intangible Assets | — | $2.5m | $1.3m | $2.2m | $1.5m | $1.5m | $504k | $290k | $287k | — | — | |
| Depreciation | $16.6m | $16.7m | $16.3m | $16.6m | $16.2m | $16k | $14.9m | $16.7m | $17.5m | $17.7m | $19.3m | |
| Depreciation, Amortization and Accretion, Net | — | $18.6m | $17.8m | $18.6m | $17.7m | $17.1m | $15.4m | $17.0m | $19.3m | $19.5m | $19.3m | |
| Deferred Income Tax Expense (Benefit) | $911k | ($2.0m) | $3.1m | ($3.4m) | ($2.2m) | $1.3m | ($1.6m) | ($3.6m) | ($9.1m) | ($6.3m) | $9.9m | |
| Deferred Other Tax Expense (Benefit) | — | — | — | $471k | — | — | — | — | — | — | — | |
| Share-based Payment Arrangement, Noncash Expense | $3.0m | $2.9m | $2.6m | $2.5m | $2.3m | $2.1m | $2.0m | $2.0m | $2.1m | $2.9m | $4.9m | |
| Payment, Tax Withholding, Share-based Payment Arrangement | — | $261k | $311k | $246k | $199k | $125k | $200k | $140k | $303k | $606k | — | |
| Share-based Payment Arrangement, Expense | $3.0m | $2.9m | $2.6m | $2.5m | $2.3m | $2.1m | $2.0m | $2.0m | $2.1m | $2.9m | $4.9m | |
| Equity Method Investment, Other than Temporary Impairment | — | — | — | — | — | — | — | $4.5m | $6.4m | $0 | — | |
| Goodwill, Impairment Loss | — | — | — | — | — | $0 | $0 | $4.6m | $0 | $0 | $0 | |
| Impairment of Intangible Assets, Finite-lived | — | $830k | $0 | $0 | — | — | — | — | — | — | — | |
| Equity Method Investment, Realized Gain (Loss) on Disposal | $119k | $0 | $0 | — | — | — | — | — | — | — | — | |
| Income (Loss) from Equity Method Investments | — | ($136k) | ($481k) | ($844k) | ($741k) | ($2.4m) | ($3.0m) | ($3.3m) | ($3.8m) | ($3.1m) | — | |
| Other Nonoperating Income (Expense) | ($128k) | ($354k) | ($537k) | ($1.1m) | ($541k) | ($3.0m) | ($3.1m) | ($7.2m) | ($13.1m) | ($17.8m) | — | |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts Receivable | ($3.8m) | $2.7m | ($2.3m) | ($10.9m) | $7.5m | ($4.9m) | $33.9m | $10.4m | $7.7m | ($25.2m) | ($54.8m) | |
| Increase (Decrease) in Inventories | $5.1m | ($3.6m) | $8.5m | $4.1m | $8.3m | ($13.9m) | $61.2m | $15.1m | ($10.9m) | ($32.5m) | ($3.4m) | |
| Increase (Decrease) in Accounts Payable | ($9.9m) | $5.5m | ($2.6m) | ($2.7m) | $2.4m | ($7.1m) | $33.0m | ($5.3m) | ($7.1m) | ($14.1m) | $28.7m | |
| Net Cash Provided by (Used in) Operating Activities | $13.3m |
$39.4m
+196.72%
|
$30.4m
-22.92%
|
$29.5m
-2.68%
|
$10.8m
-63.42%
|
$66.2m
+512.62%
|
($27.0m)
-140.83%
|
$15.0m
+155.57%
|
$63.2m
+320.93%
|
$97.7m
+54.51%
|
$49.2m
-49.63%
|
|
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Property, Plant, and Equipment | $17.1m | $8.5m | $18.1m | $17.3m | $18.1m | $7.9m | $20.4m | $25.4m | $17.0m | $19.5m | ($14.9m) | |
| Gain (Loss) on Disposition of Property Plant Equipment | $71k | ($36k) | $1.3m | $441k | $35k | $572k | $743k | $691k | ($44k) | $156k | $1.8m | |
| Payments to Acquire Businesses, Net of Cash Acquired | $7.9m | $1.6m | $0 | $2.2m | $0 | $0 | — | — | — | — | ($5.4m) | |
| Net Cash Provided by (Used in) Investing Activities | ($23.8m) | ($18.2m) | ($19.6m) | ($11.8m) | ($4.3m) | ($10.2m) | ($31.4m) | ($25.4m) | ($21.3m) | ($23.8m) | ($19.6m) | |
| Cash flows from financing activities: | ||||||||||||
| Repayments of Long-term Debt | $467k | $921k | $1.0m | $450k | $2.1m | $460k | $200k | $305k | $410k | $414k | ($2.9m) | |
| Proceeds from Issuance of Long-term Debt | — | — | — | — | — | — | — | $1.2m | $0 | $0 | $1.4m | |
| Payments for Repurchase of Common Stock | — | $1.8m | $0 | $0 | $5.6m | $0 | $3.2m | $0 | $0 | $29.5m | — | |
| Payments of Ordinary Dividends, Common Stock | $17.6m | $13.7m | $12.4m | $12.6m | $9.0m | $0 | $0 | — | — | — | — | |
| Net Cash Provided by (Used in) Financing Activities | ($17.4m) |
($16.3m)
+6.45%
|
($13.3m)
+18.75%
|
($11.9m)
+10.03%
|
($2.0m)
+83.42%
|
($15.6m)
-687.92%
|
($3.6m)
+77.05%
|
$17.6m
+591.28%
|
$15.1m
-13.92%
|
($27.4m)
-281.52%
|
($26.2m)
+4.41%
|
|
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | — | ($591k) | ($3.1m) | $6.0m | $4.7m | $40.0m | ($62.4m) | $6.7m | $57.0m | $45.8m | $131.6m | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | $4.3m | $29.8m | $35.7m | $40.4m | $80.4m | $18.0m | $24.7m | $81.7m | $127.5m | $131.6m | |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | ($591k) | ($620k) | $215k | $111k | ($416k) | ($399k) | ($522k) | ($69k) | ($653k) | $794k | |
| Additional Supplementary Disclosures | ||||||||||||
| Additional Supplementary Disclosures | ||||||||||||
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating Activities | — | — | — | — | $46k | $264k | $16k | $1.1m | $2.9m | $3.1m | — | |
| Income Taxes Paid, Net | ($824k) | $3.2m | $8.9m | ($1.9m) | $977k | $2.6m | $2.0m | $7.5m | $26.5m | $17.8m | — | |
| Additional Financial Items | ||||||||||||
| Foreign Currency Transaction Gain (Loss), before Tax | ($326k) | ($331k) | $29k | ($262k) | $207k | ($675k) | ($227k) | $479k | $284k | $658k | — | |
| General and Administrative Expense | $32.8m | $34.2m | $34.9m | $34.8m | $35.2m | $28.0m | $32.6m | $38.7m | $42.6m | $63.5m | — | |
| Goodwill | $8.1m | $7.8m | $8.3m | $7.9m | $7.7m | $8.4m | $7.9m | $3.2m | $3.2m | $3.2m | $0 | |
| Income Tax Expense (Benefit) | $1.1m | $5.2m | $6.9m | ($4.0m) | ($500k) | $3.1m | $516k | $6.5m | $19.4m | $4.3m | — | |
| Operating Expenses | $118.5m | $125.0m | $133.2m | $135.0m | $138.9m | $103.5m | $112.7m | $130.0m | $135.3m | $162.4m | — | |
| Proceeds from Stock Options Exercised | $610k | $343k | $519k | $1.3m | $0 | $0 | $8k | $21k | $1.3m | $5.2m | — | |
| Financing Receivable, Credit Loss, Expense (Reversal) | — | — | — | — | — | — | — | — | — | $15.5m | — |